Biopharm-trader-sml (@biopharm_trader) 's Twitter Profile
Biopharm-trader-sml

@biopharm_trader

ID: 1373800070722764800

calendar_today22-03-2021 00:54:08

7,7K Tweet

106 Takipçi

205 Takip Edilen

Biopharm-trader-sml (@biopharm_trader) 's Twitter Profile Photo

$CMPS Phase 3 positive. COMP360 shows rapid & durable depression response. Q4 NDA submission planned. Regulatory runway just opened.

Biopharm-trader-sml (@biopharm_trader) 's Twitter Profile Photo

$ALT stabilizing after pullbacks and building a base near support. Obesity pipeline + future data catalysts keep this one firmly on watch.

ImmunityBio, Inc. (@immunitybio) 's Twitter Profile Photo

The European Commission has granted conditional marketing authorization for ANKTIVA® (nogapendekin alfa inbakicept) in combination with BCG for adults with BCG-unresponsive non-muscle invasive bladder cancer with carcinoma in situ. This decision broadens availability across 33

Market Wire News (@marketwirenews) 's Twitter Profile Photo

Breaking News: $IBRX Stock Market Today, Feb. 18: ImmunityBio Soars After EU Approves ANKTIVA for Bladder Cancer News & Disclaimer marketwirenews.com/news-releases/… Grok please provide the finance card for $IBRX

Biopharm-trader-sml (@biopharm_trader) 's Twitter Profile Photo

Watching $ALT closely. Base building around $4.20 ahead of earnings. Key level: $4.30. Break that and momentum traders could target $4.60–$5.00. Biotech setups move fast.

Usman Ashraf (@usmanashraff) 's Twitter Profile Photo

Every trader has losing days. The ones who blow their account aren't the ones who lose. They're the ones who don't know what to do after they lose. I've been there. I figured it out. Here are the 5 steps I follow after every losing day to reset and come back stronger. (Thread

Usman Ashraf (@usmanashraff) 's Twitter Profile Photo

First, understand what's actually happening in your brain after a loss. Your brain treats a financial loss the same way it treats a physical threat. So your natural response? Keep trading. Make it back. Fix it now. That instinct is exactly what turns a losing day into a

Usman Ashraf (@usmanashraff) 's Twitter Profile Photo

Step 1: Close your screen and walk away. Not tomorrow. Right now. If you're wrong on more than 50% of your trades that day, the market is telling you something. It's not your strategy. It's not bad luck. You're not reading what the market is showing you. The most profitable

TradeZella 🦄 (@tradezella) 's Twitter Profile Photo

A trader with a 70% win rate is losing money. A trader with a 40% win rate is printing consistently. Both are real. Both are common. Here's why win rate is the most misleading stat in trading: 🧵👇

Biopharm-trader-sml (@biopharm_trader) 's Twitter Profile Photo

$ALT holding steady above $3.50 with solid intraday support 📊 Tight range = energy building… next move could be explosive 🚀 Watching for volume to step in 👀 #ALT #Biotech #Momentum

Biopharm-trader-sml (@biopharm_trader) 's Twitter Profile Photo

$ALT quietly building while most are distracted. Phase 3 MASH ahead, narrative getting stronger. Early positioning > late chasing.

Biopharm-trader-sml (@biopharm_trader) 's Twitter Profile Photo

$ALT quietly building while most are distracted. Phase 3 MASH ahead, narrative getting stronger. Early positioning > late chasing.

Biopharm-trader-sml (@biopharm_trader) 's Twitter Profile Photo

$ALT just secured $225M in an oversubscribed raise — Phase 3 for pemvidutide is fully funded. Short-term dilution, long-term acceleration. Smart money is positioning ahead of MASH data.